HMGB1 and triple-negative breast carcinoma: Key studies using multiple mouse tumors, including a triple-negative breast cancer, showed that HMGB1 drives the differentiation of MDSCs from bone marrow progenitor cells, demonstrating that HMGB1 acts at the earliest stages of MDSC development [84].